Manon Huizing

4.5k citations

98 papers · 3.0k indexed · h-index 29

Impact in

Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Orthopedics and Sports Medicine top 2%
- Bone and Joint Diseases

Papers in ⓘ

Oncology 69
- Cancer Treatment and Pharmacology 39
- HER2/EGFR in Cancer Research 13
- Colorectal Cancer Treatments and Studies 13
- Neutropenia and Cancer Infections 9
Pathology and Forensic Medicine 19
- Breast Lesions and Carcinomas 8

Co-authors: Jos H. Beijnen (28 shared papers)Jan B. Vermorken (26 shared papers)W.W. ten Bokkel Huinink (18 shared papers)Herbert M. Pinedo (9 shared papers)Tim Van den Wyngaert (12 shared papers)Hilde Rosing (13 shared papers)Olaf van Tellingen (7 shared papers)C.H.N. Veenhof (8 shared papers)
Journals: Journal of Clinical Oncology (11 papers)Annals of Oncology (9 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)The Breast Journal (3 papers)
Partner nations: Belgium Netherlands United States

In The Last Decade

Manon Huizing

95 papers receiving 2.9k citations

Peers

Countries citing papers authored by Manon Huizing

Since Specialization

Citations

This map shows the geographic impact of Manon Huizing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manon Huizing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manon Huizing more than expected).

Fields of papers citing papers by Manon Huizing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manon Huizing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manon Huizing. The network helps show where Manon Huizing may publish in the future.

Co-authors

The 25 scholars most cited alongside Manon Huizing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manon Huizing Line = papers co-authored together Manon Huizing links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial Annals of Oncology ·Géraldine Gebhart, Laetitia E. Lamberts, Zéna Wimana, Camilo Garcia, Patrick Emonts, Lieveke Ameye, Sigrid Stroobants, Manon Huizing, P. Aftimos, J. Tol, Wim J.G. Oyen, Daniëlle J. Vugts, Otto S. Hoekstra, Carolina P. Schröder, C. Willemien Menke‐van der Houven van Oordt, Thomas Guiot, Adrienne H. Brouwers, Ahmad Awada, Elisabeth G.E. de Vries, P. Flamen	2015	265
2	Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. Journal of Clinical Oncology ·Manon Huizing, Anther Keung, Hilde Rosing, V van der Kuij, W.W. ten Bokkel Huinink, I. Mandjes, Anne-Charlotte Dubbelman, Herbert M. Pinedo, Jos H. Beijnen	1993	263
3	Taxanes: A New Class of Antitumor Agents Cancer Investigation ·Manon Huizing, Vinoj H Sewberath Misser, Rob Pieters, W.W. ten Bokkel Huinink, C.H.N. Veenhof, Jan B. Vermorken, Herbert M. Pinedo, Jos H. Beijnen	1995	238
4	Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients British Journal of Cancer ·Olaf van Tellingen, Manon Huizing, Vinodh R. Nannan Panday, J. H. M. Schellens, W J Nooijen, Jos H. Beijnen	1999	159
5	Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre. Journal of Clinical Oncology ·Manon Huizing, Giuseppe Giaccone, Laurence J. van Warmerdam, Hilde Rosing, Piet Bakker, Jan B. Vermorken, Pieter E. Postmus, Nico van Zandwijk, Marijn Koolen, W.W. ten Bokkel Huinink, W J van der Vijgh, F. Bierhorst, Andrew Lai, O. Dalesio, Herbert M. Pinedo, C.H.N. Veenhof, Jos H. Beijnen	1997	159
6	Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome Annals of Oncology ·Tim Van den Wyngaert, Tom Claeys, Manon Huizing, Jan B. Vermorken, Eric Fossion	2008	116
7	High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine Journal of Chromatography B Biomedical Sciences and Applications ·Manon Huizing, Hilde Rosing, F J Koopman, Anther Keung, Herbert M. Pinedo, Jos H. Beijnen	1995	102
8	Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study Annals of Oncology ·Peter Vuylsteke, Manon Huizing, Katarína Petráková, Rebecca Roylance, Robert Laing, Stephen Chan, F. Abell, Steven Gendreau, Isabelle Rooney, Doris Apt, Jing Zhou, Stina Mui Singel, Louis Fehrenbacher	2016	91
9	Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Annals of Oncology ·Tim Van den Wyngaert, Manon Huizing, Jan B. Vermorken	2006	91
10	Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer. Journal of Clinical Oncology ·Manon Huizing, Laurence J. van Warmerdam, Hilde Rosing, Matthias Schaefers, Amanda Lai, Th.J.M. Helmerhorst, C.H.N. Veenhof, Martin Birkhofer, Sjoerd Rodenhuis, Jos H. Beijnen, W.W. ten Bokkel Huinink	1997	65
11	Osteonecrosis of the jaw related to the use of bisphosphonates Current Opinion in Oncology ·Tim Van den Wyngaert, Manon Huizing, Jan B. Vermorken	2007	64
12	Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography Journal of Chromatography B Biomedical Sciences and Applications ·Manon Huizing, Alex Sparreboom, Hilde Rosing, Olaf van Tellingen, Herbert M. Pinedo, Jos H. Beijnen	1995	59
13	Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion Cancer Chemotherapy and Pharmacology ·Hilde Rosing, Vera Lustig, L.J.C. van Warmerdam, Manon Huizing, W.W. ten Bokkel Huinink, Jan H.M. Schellens, Sjoerd Rodenhuis, A. Bult, Jos H. Beijnen	2000	56
14	Isolation, purification and biological activity of major docetaxel metabolites from human feces. Drug Metabolism and Disposition ·Alexander Sparreboom, Olaf van Tellingen, E J Scherrenburg, Jan J. B. Boesen, Manon Huizing, W J Nooijen, Cees Versluis, Jos H. Beijnen	1996	55
15	Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: A European Cancer Centre (ECC) trial Annals of Oncology ·Manon Huizing, Jan B. Vermorken, Hilde Rosing, W.W. ten Bokkel Huinink, I. Mandjes, Herbert M. Pinedo, Jos H. Beijnen	1995	54
16	Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces Cancer Chemotherapy and Pharmacology ·Alexander Sparreboom, Manon Huizing, Jan J. B. Boesen, Willem J. Nooijen, Olaf van Tellingen, Jos H. Beijnen	1995	54
17	Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study The Lancet Oncology ·Ahmad Awada, Agustin A. García, Stephen L. Chan, Guy Jérusalem, Robert E. Coleman, Manon Huizing, Aminder Mehdi, Sue M O'Reilly, John Hamm, Peter Barrett‐Lee, Véronique Cocquyt, Kostandinos Sideras, David Young, Carol Zhao, Yen Lin Chia, Ute Hoch, Alison L. Hannah, Edith A. Perez	2013	49
18	RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem? Supportive Care in Cancer ·Tim Van den Wyngaert, Kristien Wouters, Manon Huizing, Jan B. Vermorken	2011	47
19	High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. PubMed ·Jan B. Vermorken, W.W. ten Bokkel Huinink, Ingrid A.M. Mandjes, Tjeerd J. Postma, Manon Huizing, J.J. Heimans, Jos H. Beijnen, F. Bierhorst, Benjamin Winograd, (unknown)	1995	47
20	SARS-CoV-2 and cancer: Are they really partners in crime? Cancer Treatment Reviews ·Peter A. van Dam, Manon Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altıntaş, Jan B. Vermorken, Christof Vulsteke, Annelies Janssens, Zwi Berneman, Hans Prenen, Leander Meuris, Wim Vanden Berghe, Evelien Smits, Marc Peeters	2020	45

About Manon Huizing

Manon Huizing is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Dermatology and Reproductive Medicine, having authored 98 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (39 papers), HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Breast Cancer Treatment Studies (13 papers), Neutropenia and Cancer Infections (9 papers), Cancer therapeutics and mechanisms (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Breast Lesions and Carcinomas (8 papers). The work is most often cited by research in Oncology (2.2k citations), Orthopedics and Sports Medicine (277 citations), Pharmacology (276 citations), Cancer Research (349 citations) and Radiology, Nuclear Medicine and Imaging (365 citations). Manon Huizing has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Jos H. Beijnen, Jan B. Vermorken, W.W. ten Bokkel Huinink, Herbert M. Pinedo, Tim Van den Wyngaert, Hilde Rosing, Olaf van Tellingen, C.H.N. Veenhof, Anther Keung and Vinodh R. Nannan Panday. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Obstetrics & Gynecology and Reproductive Biology, Cancer Chemotherapy and Pharmacology and The Breast Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact